Claims for Patent: 4,617,271

Summary for Patent: 4,617,271

Title:	Process for producing immobilized L-asparaginase preparations for the therapy of leukemia
Abstract:	This invention relates to a process for producing immobilized L-asparaginase preparations. Its principal object is to produce immobilized L-asparaginase preparations which are excellent in antithrombogenicity and mechanical strength. The present invention is concerned with production of immobilized L-asparaginase preparations by pouring an aqueous solution containing 6% or more of a polyvinyl alcohol with a degree of hydrolysis of 97 mol. % or higher and a viscosity-average degree of polymerization of 1,800 or more an antileukemic asparaginase into a vessel or a mold of an appropriate shape, subjecting the solution to cooling, solidification and molding at a temperature of -15.degree. C. or lower and partially dehydrating the molded mass without thawing to a dehydration ratio of 5% by weight or more and, if desired, immersing the product in water. According to the invention, L-asparaginase can be embedded in a highly hydrous gel excellent in antithrombogenicity and mechanical strength by simple procedures.
Inventor(s):	Nambu; Masao (Yokohama, JP)
Assignee:	Nippon Oil Company, Limited (Tokyo, JP)
Application Number:	06/573,922
Patent Claims:	1. A process for producing immobilized L-asparaginase preparations for the therapy of leukemia which comprises pouring an aqueous solution containing 6% by weight or more of a polyvinyl alcohol with a degree of hydrolysis of 97 mol. % or higher and a degree of polymerization of 1,800 or more and an antileukemic asparaginase into a vessel of a desired shape and subjecting the solution to cooling and solidification at a temperature lower then -15.degree. C., and then partially dehydrating the resulting solidified mass without thawing to a dehydration ratio of 5% by weight or more to obtain a desired gel. 2. The process according to claim 1 wherein heparin is added to the aqueous solution. 3. The process according to claim 1 or 2 wherein concentration of the polyvinyl alcohol in the aqueous solution is from 6 to 25% by weight. 4. The process according to any one of claims 1-3 wherein the cooling, solidification and molding temperature is -35.degree. C. or below. 5. The process according to any one of claim 1-4 wherein dehydration ratio in the partial dehydration step is 15% by weight or more. 6. The process according to any one of claims 1-5 wherein the partial dehydration is conducted by vacuum dehydration. 7. The process according to any one of the claims 1-6 wherein the water content of the obtained gel is increased by immersing said gel in water to give a water content of 45 to 92% by weight.

Details for Patent 4,617,271

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Recordati Rare Diseases, Inc.	ELSPAR	asparaginase	For Injection	101063	01/10/1978		2003-10-14